Related Experiment Video
Updated: Feb 28, 2026

04:01
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
2.0K
Selenium-Thioredoxin Axis Contributes to Ferroptosis Resistance in Pancreatic Cancer Cells
Arslan Amer1, Micah Idowu1, Aqsa Ahsan1
1Department of Biological Sciences, Michigan Technological University, Houghton, MI 49931, USA.
International Journal of Molecular Sciences
|February 27, 2026
Summary
Pancreatic cancer cells show varied responses to ferroptosis. A selenium-thioredoxin pathway, independent of GPX4, confers resistance in epithelial cells, suggesting new therapeutic targets.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Pancreatic ductal adenocarcinoma (PDAC) exhibits significant heterogeneity in cysteine dependency and ferroptosis sensitivity.
- Two PDAC subtypes, mesenchymal-like and epithelial-type, display distinct vulnerabilities and resistance mechanisms.
- Current understanding of ferroptosis resistance in PDAC requires further elucidation of underlying pathways.
Purpose of the Study:
- To investigate the mechanisms of ferroptosis resistance in epithelial-type PDAC cells.
- To identify novel pathways contributing to ferroptosis resistance beyond glutathione peroxidase 4 (GPX4).
- To explore the role of selenium and thioredoxin reductases in PDAC ferroptosis.
Main Methods:
- Comparative analysis of PDAC subtypes based on epithelial-mesenchymal transition (EMT) status.
- Assessment of ferroptosis sensitivity upon cystine deprivation or system xc- inhibition.
- Evaluation of selenium supplementation effects on ferroptosis and glutathione (GSH) levels.
- Investigation of thioredoxin reductases (TrxR1 and TrxR2) inhibition on ferroptosis sensitivity and selenium protection.
Main Results:
- Mesenchymal-like PDAC cells are cysteine-dependent and sensitive to ferroptosis, while epithelial-type cells are resistant.
- Selenium supplementation protects against ferroptosis independently of GPX4 and GSH levels.
- Epithelial-type cells utilize both TrxR1 and TrxR2 for ferroptosis resistance.
- Inhibition of thioredoxin reductases abrogates selenium-mediated protection and sensitizes cells to ferroptosis.
Conclusions:
- A novel selenium-thioredoxin redox axis, independent of GPX4, confers ferroptosis resistance in epithelial-type PDAC.
- Targeting cysteine metabolism and thioredoxin reductases presents a potential therapeutic strategy for resistant PDAC subtypes.
- Understanding PDAC heterogeneity is crucial for developing effective ferroptosis-based cancer therapies.
Related Concept Videos
Electron Transport Chain: Complex I and II
19.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.2K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Necrosis
6.9K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.9K